SHEA is deeply disappointed by the sudden departure of the CDC Director so soon after her confirmation, at a time when the agency most needs stability and authority to carry out its vital mission of protecting the health and safety of all Americans. The United States stands at a critical crossroads, where strong, trusted public health leadership is essential to restoring confidence through evidence-based practices and guidance. In an era marked by increasing assaults on science and public health, CDC must be empowered to rise above politics and remain focused on their core purpose: safeguarding and improving the health of communities. While there may be differing perspectives on how best to achieve this goal, it is clear that qualified, steady leadership is indispensable to guiding the path forward. We urge the Administration and Senate leadership to move swiftly to appoint a highly qualified leader who can steer the CDC through today’s urgent challenges and prepare for those to come, including any future pandemics. The CDC is not only central to protecting Americans from health threats but also to strengthening health outcomes and ensuring a healthier future for all.

Next to cancer recurrence or progression, cardiovascular diseases are the leading causes of death in cancer survivors. The Surveillance, Epidemiology, and End Results database revealed that among the more than three million who initially survived cancer between 1973 and 2012, 38% eventually succumbed to the disease while 11.3% died from cardiovascular diseases.  Specifically, cancer survivors are at a four to seven-fold higher risk of venous thromboembolism (VTE), which proves fatal in one out of seven cancer patients.

While the effects of high-fat diets have been studied in the context of cancer and cardiovascular disease, sparse information is available on the impact of a high-protein diet and cancer-associated thrombosis.

In a new study researchers have found that a high protein diet, or a diet high in amino acid tryptophan (Trp). Trp is abundant in various protein-rich foods increases the risk of cancer-associated VTE in experimental models.

The Cardiovascular Research Foundation^® (CRF^®) is excited to announce the late-breaking clinical trials and science set to be presented at TCT^® 2025, the annual scientific symposium of CRF^® and the world’s premier educational meeting specializing in interventional cardiovascular medicine. This year’s conference will take place October 25–28 at the Moscone Center in San Francisco, bringing together top experts, innovators, and clinicians from around the globe.